Edelstein M B, Smink T, Ruiter D, van Putten L M
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1147-51. doi: 10.1016/0277-5379(85)90006-9.
Using the subrenal capsule assay modified by us in order to decrease the ingrowth of host cells, evaluation of the growth kinetics of three human ovarian tumors and one human lung tumor were made by multiple measurements of the tumor implantation site over the 6-day growth period. For all tumors, a lag period of 2-3 days was noticed before growth occurred in the subrenal location. In general, estimation of the composition of the fragments growing under the renal capsule did not change greatly in terms of percentage tumor of which they consisted but by day 6 most had shown a significant degree of host cell infiltration despite the effects of pre-implantation immunosuppression. We would suggest that only certain human tumors are suitable for implantation using this technique. Further, it appears that within even this group of selected tumors only some are suitable for drug studies, those having established exponential growth early enough so that a measurable endpoint can be reached within the 6-day time limit of the assay.
为了减少宿主细胞的长入,我们对肾包膜下接种试验进行了改进,通过在6天的生长期间对肿瘤接种部位进行多次测量,评估了三种人类卵巢肿瘤和一种人类肺肿瘤的生长动力学。对于所有肿瘤,在肾包膜下生长出现之前,均观察到2-3天的延迟期。总体而言,尽管进行了植入前免疫抑制,但在肾包膜下生长的碎片组成估计在其所包含的肿瘤百分比方面变化不大,但到第6天,大多数碎片已显示出显著程度的宿主细胞浸润。我们认为只有某些人类肿瘤适合使用这种技术进行植入。此外,即使在这组选定的肿瘤中,似乎也只有一些适合进行药物研究,即那些足够早地建立指数生长,以便在试验的6天时间限制内能够达到可测量终点的肿瘤。